Use of ropeginterferon in inducing graft versus myelofibrosis effect in post‐transplant myelofibrosis relapse

Key Clinical Message Here, we describe a patient with post‐transplant myelofibrosis with chronic graft‐versus‐host disease (GVHD), who showed successful molecular remission with ropeginterferon with 100% donor chimerism without any flare up of GVHD. He was initially diagnosed with polycythemia vera...

Cijeli opis

Bibliografski detalji

Glavni autori:	Barnali Srivastava, Christine Wolschke, Nico Gagelmann, Anita Badbaran, Nicolaus Kröger
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2023-09-01
Serija:	Clinical Case Reports
Teme:	graft versus host disease graft versus myelofibrosis MTSS score (myelofibrosis transplant scoring system) myelofibrosis MYSEC score (myelofibrosis secondary to PV and ET‐prognostic model) ropeginterferon
Online pristup:	https://doi.org/10.1002/ccr3.7942
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!